We are live on ! Find out more
ALIM

Alimera Sciences
ALIM

Delisted

ALIM was delisted on the 13th of September, 2024.

Back to rankings

41 hedge funds and large institutions have $39M invested in Alimera Sciences in 2017 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 6

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

9% more capital invested

Capital invested by funds: $35.7M → $39M (+$3.29M)

8% more funds holding

Funds holding: 38 → 41 (+3)

46% less call options, than puts

Call options by funds: $15K | Put options by funds: $28K

Holders
41
Holders Change
+3
Holders Change %
+7.89%
% of All Funds
1.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
11
Reduced
6
Closed
5
Calls
$15K
Puts
$28K
Net Calls
-$13K
Net Calls Change
-$28K

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$1.83M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$668K
3
Renaissance Technologies
Renaissance Technologies
New York
+$572K
4
AC
Armistice Capital
New York
+$519K
5
ACA
Avoro Capital Advisors
New York
+$499K

Top Sellers

Rank Fund Capital Flow
1
PL
Parkwood LLC
Ohio
-$317K
2
Goldman Sachs
Goldman Sachs
New York
-$264K
3
ARTA
A.R.T. Advisors
New York
-$115K
4
Citadel Advisors
Citadel Advisors
Florida
-$31.9K
5
AIM
Acrospire Investment Management
Illinois
-$15K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$8.46M +$519K +24,267 +6%
ACA
2
Avoro Capital Advisors
New York
$8.43M +$499K +23,333 +6%
DM
3
Deerfield Management
New York
$8.17M +$1.83M +85,559 +27%
PAI
4
Palo Alto Investors
California
$4.07M – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$2.79M +$668K +31,230 +29%
ACP
6
Acuta Capital Partners
California
$1.31M – – –
JAM
7
JW Asset Management
Florida
$1.3M – – –
BCM
8
Bridgeway Capital Management
Texas
$796K +$285K +13,334 +51%
SCM
9
Stonepine Capital Management
Oregon
$644K +$417K +19,493 +158%
Renaissance Technologies
10
Renaissance Technologies
New York
$632K +$572K +26,740 +600%
O
11
OrbiMed
New York
$338K – – –
BlackRock
12
BlackRock
New York
$273K +$2.85K +133 +1%
DMK
13
David M. Knott
$269K +$284K +13,267 New
Deutsche Bank
14
Deutsche Bank
Germany
$259K +$262K +12,235 +2,139%
PNC Financial Services Group
15
PNC Financial Services Group
Pennsylvania
$243K – – –
Geode Capital Management
16
Geode Capital Management
Massachusetts
$211K – – –
Goldman Sachs
17
Goldman Sachs
New York
$160K -$264K -12,331 -61%
Northern Trust
18
Northern Trust
Illinois
$139K – – –
WMSA
19
Weiss Multi-Strategy Advisers
New York
$108K -$5.71K -267 -5%
SO
20
STRS Ohio
Ohio
$58K – – –
SCM
21
Southport Capital Management
Tennessee
$45K -$128 -6 -0.3%
JP Morgan Chase
22
JP Morgan Chase
New York
$37K +$19.1K +893 +95%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$36K – – –
TRCT
24
Tower Research Capital (TRC)
New York
$33K +$35K +1,636 New
ICOA
25
Investment Centers of America
North Dakota
$32K – – –
1
2

ALIM Hedge Fund Activity: Q3 2017 in Review

41 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q3 2017, worth a combined $39M — up 9.2% from $35.7M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new ALIM positions and 5 closed out — a net gain of 4 holders — while 11 added to existing stakes and 6 trimmed.

The largest buyer was Deerfield Management, adding an estimated $1.83M. The largest seller was Parkwood LLC, exiting entirely with an estimated $317K sold.

  • 41 institutional investors held Alimera Sciences (ALIM) as of Q3 2017, up from 38 in Q2 2017.
  • Funds reported $39M of Alimera Sciences stock for Q3 2017, up 9.2% quarter-over-quarter.
  • 9 funds opened new Alimera Sciences positions in Q3 2017 and 5 closed out, a net change of +4 holders.
  • The largest Alimera Sciences buyer in Q3 2017 was Deerfield Management, an estimated $1.83M added.
  • The largest Alimera Sciences seller in Q3 2017 was Parkwood LLC, an estimated $317K sold.

Based on aggregated 13F filings for Q3 2017.